These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 50555)

  • 21. [Analysis of factors affecting clinical cancer chemotherapy].
    Wakui A; Taguchi T
    Gan No Rinsho; 1983 Aug; 29(10):1199-204. PubMed ID: 6415312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I alternate-day dose study of chromomycin A3.
    Reynolds RD; Fisher JI; Jensen PA; Pajak TF; Bateman JR
    Cancer Treat Rep; 1976 Sep; 60(9):1251-5. PubMed ID: 1035132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleomycin, vincristine, and mitomycin C with or without methotrexate in the treatment of squamous cell carcinoma.
    Wheeler RH; Liepman MK; Baker SR; Earhart RH; Bull FE; Ensminger WD
    Cancer Treat Rep; 1980; 64(8-9):943-9. PubMed ID: 6160914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled studies with bleomycin in solid tumors and lymphomas.
    Bonadonna G; Tancini G; Bajetta E
    Prog Biochem Pharmacol; 1976; 11():172-84. PubMed ID: 63961
    [No Abstract]   [Full Text] [Related]  

  • 25. Feasibility study of combining metronidazole with chemotherapy.
    Stewart DJ; Maroun JA; Young V; Crook AF; Hopkins HS; Yan RC; Richard MT; Hugenholtz H; Bélanger R; Heringer R
    J Clin Oncol; 1983 Jan; 1(1):17-23. PubMed ID: 6422002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infusion versus perfusion.
    Golomb FM
    Aktuelle Probl Chir; 1970; 14():835-57. PubMed ID: 4124391
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy of residual disease in solid tumours.
    Kenis Y
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):103-7. PubMed ID: 4324078
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.
    Krauss S; Sonoda T; Solomon A
    Cancer; 1979 May; 43(5):1598-603. PubMed ID: 445355
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical study of 47 patients with stomach cancer treated with mitomycin C].
    Paolucci R
    Cancro; 1971; 24(3):153-9. PubMed ID: 4949673
    [No Abstract]   [Full Text] [Related]  

  • 30. [Are combinations more effective than monotherapy in the matter of antiocancer chemotherapy?].
    Horton J; Olson K
    Poumon Coeur; 1968; 24(1):59-62. PubMed ID: 4968016
    [No Abstract]   [Full Text] [Related]  

  • 31. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
    Cersosimo RJ; Hong WK
    J Clin Oncol; 1986 Mar; 4(3):425-39. PubMed ID: 3005521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor effect of KW2149, a new mitomycin derivative, administered by different modalities.
    Nishiyama M; Kim R; Jinushi K; Takagami S; Kirihara Y; Toge T
    In Vivo; 1989; 3(6):375-9. PubMed ID: 2519881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of polychemotherapy of cancer of the digestive organs].
    Singer Z; Kobylińska-Scieszkowa M; Dzieza-Lalowicz I; Starzewska H; Rogoń Z; Gejsler A
    Pol Tyg Lek; 1980 Sep; 35(38):1453-5. PubMed ID: 7465441
    [No Abstract]   [Full Text] [Related]  

  • 34. [US-Japan Cooperative Cancer Research Program--adjuvant and neo-adjuvant chemotherapy].
    Ogawa M
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1175-9. PubMed ID: 3566311
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemotherapy of malignant tumors using massive-dose administration of Endoxan].
    Pigatto JC
    Munch Med Wochenschr; 1967 Oct; 109(40):2082-4. PubMed ID: 4873942
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase I study of 7-N-(p-hydroxyphenyl)-mitomycin C.
    Meguro S; Nagata T; Yokoyama K; Chinen T; Yamazaki H; Kobayashi T; Isogai Y; Ogawa M
    Invest New Drugs; 1984; 2(4):381-5. PubMed ID: 6511242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitomycin and methotrexate: negative experience in untreated colorectal carcinoma.
    Wernz JC; Kao AK; Muggia FM; Asbury RF
    Cancer Treat Rep; 1985 Feb; 69(2):223-4. PubMed ID: 3918793
    [No Abstract]   [Full Text] [Related]  

  • 38. [Phase I-II study of 7-N-(P-hydroxyphenyl)-mitomycin C (KW2083, M83)].
    Meguro S; Nagata T; Yokoyama K; Chinen T; Kobayashi T; Yamazaki H; Kuraishi Y; Ichiba ; Abe M; Isogai Y
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1818-22. PubMed ID: 6476844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent advanced studies on mitomycins, antitumor activity and mode of action].
    Taguchi T; Morimoto M
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2396-409. PubMed ID: 3111386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gastrointestinal tumors. Prognostic factors and chemotherapy of today].
    Joss R; Goldhirsch A; Tschopp L; Brunner K
    Dtsch Med Wochenschr; 1981 Dec; 106(49):1664-9. PubMed ID: 7308009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.